3
Announcements
Trials
Browse
Landscape
Phase
Phase 2
1
Status
Not yet recruiting
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Thoracic
1
Conditions
Prostatic Neoplasms
8
Breast Neoplasms
7
Carcinoma, Non-Small-Cell Lung
5
Neoplasms
4
Pancreatic Neoplasms
3
Nasopharyngeal Carcinoma
3
Uterine Cervical Neoplasms
2
Sarcoma
2
Neoplasm Metastasis
2
Meningioma
2
Liver Neoplasms
2
HER2-positive Breast Cancer
2
Glioma
2
Glioblastoma
2
Chordoma
2
Carcinoma, Hepatocellular
2
Carcinoma, Adenoid Cystic
2
Brain Neoplasms
2
Uterine Neoplasms
1
Triple Negative Breast Neoplasms
1
Stage I Prostate Adenocarcinoma AJCC v7
1
Squamous Cell Carcinoma of Head and Neck
1
Small Cell Lung Carcinoma
1
Sinonasal undifferentiated carcinoma
1
Resectable Lung Non-Small Cell Carcinoma
1
Radiation Injuries
1
Pituitary Neoplasms
1
Oligodendroglioma
1
Neurilemmoma
1
Nerve Sheath Neoplasms
1
Interventions
Radiotherapy
24
Radiotherapy, Intensity-Modulated
8
Radiosurgery
6
Amifostine
5
Low-Level Light Therapy
4
Donepezil
4
Cisplatin
4
Carboplatin
4
Surveys and Questionnaires
3
Radiation
3
Proton Therapy
3
Paclitaxel
3
Neuropsychological Tests
3
Heavy Ion Radiotherapy
3
Etoposide
3
Chemotherapy, Adjuvant
3
Chemoradiotherapy
3
Brachytherapy
3
Bevacizumab
3
Surgical Procedures, Operative
2
Radiation Dose Hypofractionation
2
Patient Reported Outcome Measures
2
Mental Status and Dementia Tests
2
Esophagectomy
2
Androgen Antagonists
2
Adrenal Cortex Hormones
2
sodium propionate
1
sargramostim
1
olaparib
1
endostar protein
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
OTHER
×
Radiation Injuries
×
Protons
×
Clear all
NCT05548504
2022-09-21
HERAN2
Odense University Hospital
Phase 2
Not yet recruiting
182 enrolled